Pacak K, Timmers HJ, Taieb D, Lenders JWM, Eisenhofer G. Pheochromocytoma In: Robertson RP, ed. DeGroot’s textbook of Endocrinology, 8th ed. Elsevier: 2023.

Lenders JW, Duh QY, Eisenhofer G, et al; Endocrine Society. Pheochromocytoma and paraganglioma: An endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2014;99(6):1915-42. https://pubmed.ncbi.nlm.nih.gov/24893135. https://doi.org/10.1210/jc.2014-1498. Erratum in: J Clin Endocrinol Metab. 2023;108(5):e200. https://pubmed.ncbi.nlm.nih.gov/24893135. https://doi.org/10.1210/clinem/dgad064.

Lenders JWM, Kerstens MN, Amar L, et al. Genetics, diagnosis, management and future directions of research of phaeochromocytoma and paraganglioma: A position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of Hypertension. J Hypertens. 2020;38(8):1443-56. https://pubmed.ncbi.nlm.nih.gov/32412940. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7486815. https://doi.org/10.1097/HJH.0000000000002438.

Ando Y, Ono Y, Sano A, Fujita N, Ono S, Tanaka Y. Clinical characteristics and outcomes of pheochromocytoma crisis: A literature review of 200 cases. J Endocrinol Invest. 2022;45(12):2313-28. https://pubmed.ncbi.nlm.nih.gov/35857218. https://doi.org/10.1007/s40618-022-01868-6.

Guerrero MA, Schreinemakers JM, Vriens MR, et al. Clinical spectrum of pheochromocytoma. J Am Coll Surg. 2009;209(6):727-32. https://pubmed.ncbi.nlm.nih.gov/19959041. https://doi.org/10.1016/j.jamcollsurg.2009.09.022.

Araujo-Castro M, Pascual-Corrales E, NatteroChavez L, et al. Protocol for presurgical and anesthetic management of pheochromocytomas and sympathetic paragangliomas: A multidisciplinary approach. J Endocrinol Invest. 2021;44(12):2545-55. https://pubmed.ncbi.nlm.nih.gov/34304388. https://doi.org/10.1007/s40618-021-01649-7.

Urabe F, Kimura S, Iwatani K, al. Risk factors for perioperative hemodynamic instability in pheochromocytoma: A systematic review and meta-analysis. J Clin Med. 2021;10(19):4531. https://pubmed.ncbi.nlm.nih.gov/34640549. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8509814. https://doi.org/10.3390/jcm10194531.

Bravo EL, Tagle R. Pheochromocytoma: State-of-the-art and future prospects. Endocr Rev. 2003;24(4):539-53. https://pubmed.ncbi.nlm.nih.gov/12920154. https://doi.org/10.1210/er.2002-0013.

Murphy MM, Witkowski ER, Ng SC, et al. Trends in adrenalectomy: A recent national review. Surg Endosc. 2010;24(10):2518-26. https://pubmed.ncbi.nlm.nih.gov/20336320. https://doi.org/10.1007/s00464-010-0996-z.

Azadeh N, Ramakrishna H, Bhatia NL, Charles JC, Mookadam F. Therapeutic goals in patients with pheochromocytoma: A guide to perioperative management. Ir J Med Sci. 2016;185(1):43-9. https://pubmed.ncbi.nlm.nih.gov/26650752. https://doi.org/10.1007/s11845-015-1383-5.

Akiba M, Kodama T, Ito Y, Obara T, Fujimoto Y. Hypoglycemia induced by excessive rebound secretion of insulin after removal of pheochromocytoma. World J Surg. 1990;14(3):317-24. https://pubmed.ncbi.nlm.nih.gov/2195784. https://doi.org/10.1007/BF01658514.

Mamilla D, Araque KA, Brofferio A, et al. Postoperative management in patients with pheochromocytoma and paraganglioma. Cancers (Basel). 2019;11(7):936. https://pubmed.ncbi.nlm.nih.gov/31277296. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6678461. https://doi.org/10.3390/cancers11070936.

Amar L, Fassnacht M, Gimenez-Roqueplo AP, et al. Long-term postoperative follow-up in patients with apparently benign pheochromocytoma and paraganglioma. Horm Metab Res. 2012;44(5):385-9. https://pubmed.ncbi.nlm.nih.gov/22351478. https://doi.org/10.1055/s-0031-1301339.

Granberg D, Juhlin CC, Falhammar H. Metastatic pheochromocytomas and abdominal paragangliomas. J Clin Endocrinol Metab. 2021;106(5):e1937-52. https://pubmed.ncbi.nlm.nih.gov/33462603. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8063253. https://doi.org/10.1210/clinem/dgaa982.

Thompson LD. Pheochromocytoma of the Adrenal gland Scaled Score (PASS) to separate benign from malignant neoplasms: A clinicopathologic and immunophenotypic study of 100 cases. Am J Surg Pathol. 2002;26(5):551-66. https://pubmed.ncbi.nlm.nih.gov/11979086. https://doi.org/10.1097/00000478-200205000-00002.

Nölting S, Bechmann N, Taieb D, et al. Personalized management of pheochromocytoma and paraganglioma. Endocr Rev. 2022;43(2):199-239. https://pubmed.ncbi.nlm.nih.gov/34147030. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8905338. https://doi.org/10.1210/endrev/bnab019. Erratum in: Endocr Rev. 2022;43(2):440. https://pubmed.ncbi.nlm.nih.gov/34904637. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8905331. https://doi.org/10.1210/endrev/bnab044. Corrigendum to: Endocr Rev. 2022 Mar 9;43(2):437-9. https://pubmed.ncbi.nlm.nih.gov/34904662. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8905330. https://doi.org/10.1210/endrev/bnab045.

Young WF. Endocrine hypertension. In: Melmed S, Auchus RJ, Goldfine AB, Koenig RJ. Williams textbook of Endocrinology, 14th ed. Philadelphia: Elsevier. 2020.